Design
Review
Key result
Heart failure is a global health burden affecting 23 million people, with management evolving from digitalis to neurohormonal antagonists, mechanical circulatory support, and emerging therapies.
Authors
Loading...
Supports guideline-directed HF care amid evolving options; leaves open the impact of emerging therapies on outcomes.
Karki et al. (2021) conducted a review in Heart Failure. Heart failure is a global health burden affecting 23 million people, with management evolving from digitalis to neurohormonal antagonists, mechanical circulatory support, and emerging therapies.